AgelessRx, a leading telehealth platform specializing in longevity, has expanded its services to include sleep health. Recognizing the crucial...

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical Co., Ltd. plan to submit a Biologics License Application...

New guidelines presented at the 2024 American College of Rheumatology (ACR) Convergence address the critical need for effective lupus...

Vir Biotechnology announced a positive opinion from the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) regarding...

Incyte, a global biopharmaceutical company, has temporarily halted enrollment in its Phase 2 clinical trial evaluating MRGPRX2 (INCB000262) for...

Adicet Bio has initiated a Phase 1 clinical trial for ADI-270, a novel cancer therapy. This trial focuses on...

Silence Therapeutics recently unveiled end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, an siRNA therapy, in individuals...

Innate Pharma announced preclinical data demonstrating the potential of IPH6501, its proprietary NK cell engager, for B-cell non-Hodgkin lymphoma...

In a recent discussion with Jena Daniels, VP of Patient Success at Medable, we explored the company’s recognition as...

Boston Pharmaceuticals announced positive Phase 2 study results for efimosfermin alfa, a long-acting FGF21 analogue, in patients with stage...